— Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX) reported its third-quarter 2019 adjusted earnings of $0.17 per share and GAAP loss of $0.03 per share. The results came in line with the analysts’ expectations.
— Revenue increased by 3% to $444 million and adjusted revenue rose by 1% to $445 million. This is compared to the consensus estimates of $450.16 million.
— Bookings jumped by 19% to $236 million in the third quarter of 2019. Contract revenue backlog totaled $3.9 billion as of September 30, 2019.
— Looking ahead, the company expects revenue growth to improve as it benefits from the strategic investments across both its Provider and Veradigm businesses.
— For the full year 2019, the company narrowed its adjusted earnings guidance to the range of $0.67 to $0.70 per share from the previous range of $0.65 to $0.70 per share. The street’s view is $0.68 per share.
— Bookings are still anticipated to be in the range of $1.05 billion to $1.10 billion for the full year.
— Adjusted revenue outlook is reiterated in the range of $460 million to $470 million for the fourth quarter of 2019 versus the consensus estimates of $462.74 million.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
